News
Triaminic and Theraflu Syrups Recalled, Child-Resistant Caps Fail
Kathleen Lees
First Posted: Feb 01, 2013 01:17 PM EST
If you're looking to cure your cough, some prescriptions won't be on the market any longer this season.
As of Thursday, Novartis AG said it is recalling 183 lots of cough syrup after discovering that their child-resistant feature for some bottle caps has not been functioning properly according to FoxNews.com.
The Swiss drug company is also recalling 142 lots of Triaminic and 41 lots of Theraflu Arming Relief Syrups that were manufactured in the United States before December 2011.
The company has so far received four reports of accidental ingestion of the Triaminic syrup. One patient required medical attention but recovered.
Though no adverse affects have been reported with the Theraflu syrup, the product is being recalled because it has the same cap as the malfunctioning Triaminic bottles.
The affected cough syrup bottles were produced at Novartis' Lincoln, Nebraska, manufacturing facility. A consumer complaint last November triggered an internal investigation that led the company to issue the recall.
Julie Masow, a spokeswoman for Novartis, said 97 percent of the product in question has either been used or already returned.
Manufacturing at the Lincoln, Nebraska, facility was suspended in December 2011 and has yet to reopen, Masow said in a statement.
It's unfortunate that winter is the most common time for the cold season...not due to the cold weather but because we are more often in close proximity to each other and more likely to spread viruses and germs according to Science Magazine. And unfortunately at this time, that just might mean our favorite medicine isn't on the shelves.
See Now:
NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone
©2024 ScienceWorldReport.com All rights reserved. Do not reproduce without permission. The window to the world of science news.
More on SCIENCEwr
First Posted: Feb 01, 2013 01:17 PM EST
If you're looking to cure your cough, some prescriptions won't be on the market any longer this season.
As of Thursday, Novartis AG said it is recalling 183 lots of cough syrup after discovering that their child-resistant feature for some bottle caps has not been functioning properly according to FoxNews.com.
The Swiss drug company is also recalling 142 lots of Triaminic and 41 lots of Theraflu Arming Relief Syrups that were manufactured in the United States before December 2011.
The company has so far received four reports of accidental ingestion of the Triaminic syrup. One patient required medical attention but recovered.
Though no adverse affects have been reported with the Theraflu syrup, the product is being recalled because it has the same cap as the malfunctioning Triaminic bottles.
The affected cough syrup bottles were produced at Novartis' Lincoln, Nebraska, manufacturing facility. A consumer complaint last November triggered an internal investigation that led the company to issue the recall.
Julie Masow, a spokeswoman for Novartis, said 97 percent of the product in question has either been used or already returned.
Manufacturing at the Lincoln, Nebraska, facility was suspended in December 2011 and has yet to reopen, Masow said in a statement.
It's unfortunate that winter is the most common time for the cold season...not due to the cold weather but because we are more often in close proximity to each other and more likely to spread viruses and germs according to Science Magazine. And unfortunately at this time, that just might mean our favorite medicine isn't on the shelves.
See Now: NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone